Polyplus
1 known investors
Polyplus (part of Sartorius) develops transfection reagents and plasmid/viral vector engineering products used in the production of viral vectors, functional proteins, and antibodies. Its solutions support gene and cell therapy manufacturing and protein expression across bacterial, yeast, and mammalian cell systems.
BiotechDeep TechHealthtech
Investors · 1
Frequently asked questions
- What does Polyplus do?
- Polyplus (part of Sartorius) develops transfection reagents and plasmid/viral vector engineering products used in the production of viral vectors, functional proteins, and antibodies. Its solutions support gene and cell therapy manufacturing and protein expression across bacterial, yeast, and mammalian cell systems.
- Who are Polyplus's investors?
- Polyplus's investors include ARCHIMED Japan.